
1st
SENDYGlycanostics is an innovative start-up focused on early-stage cancer detection, offering a clinically validated, affordable, and non-invasive liquid biopsy test for prostate cancer. Their next-generation diagnostic solution aims to revolutionize cancer screening, making it accessible and efficient for patients everywhere.